CTRI/2022/07/044150Not yet recruiting未知
Clinical Efficacy Of Herbal Compound In Irritable Bowel Syndrome
Himalayiya Ayurvedic Medical College and Hospital Dehradun0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1.Patients willing to participate in the study.
- •2.Patients irrespective of sex, religion, occupation will be selected for study with age between 18-70 years.
- •3.Patients having sign and symptoms of Grahani Dosha and who are diagnosed with IBS according to standard ROME IIIrd criteria.
- •4.Previously diagnosed case of IBS
Exclusion Criteria
- •1.Patients not willing to participate in the study.
- •2.Patients of either sex below 18 years & above 70 years will be excluded from the study.
- •3.Ulcerative colitis, Crohnâ??s disease, gastric ulcerations and other inflammatory bowel
- •conditions, Parasitic infestation
- •4.Amoebic dysentery, acute diarrhoea, bleeding per rectum
- •5.Patients on prolonged medication with NSAIDs, analgesics or any other drugs that may have an influence on the outcome of the study
- •6.Alcoholic and/or drug abusers.
- •7.History of hypersensitivity to the trail drugs or any of its ingredients.
- •8.Pregnant /lactating woman.
- •9.Patients who have completed participation in any other clinical trial during the past 6 months.
- •10.Patents with diabetes mellitus, poorly controlled hypertension, Thyroid disorders and any other autoimmune disorders
Investigators
Similar Trials
Recruiting
Phase 2
Clinical effects of a herbal formulation in relieving inflammation and joint painsosteoarthritis.Arthrosis, unspecifiedIRCT20131219015870N2Vice chancellor for research of Kermanshah University of Medical Sciences60
Not yet recruiting
Phase 2
Clinical evaluation of herbal formulations in adults with acute/chronic pain and inflammatioCTRI/2023/07/055425Plant Ayu Life Sciences LLP Pune
Completed
Phase 3
Efficacy and Safety of an Herbal-Based Medication vs. Placebo in Preventing Acute Otitis Media in Children at High Risk of Recurrence: A Prospective, Placebo Controlled, Randomized, double-blinded Parallel-Group Comparison for SuperiorityAcute Otitis Media (AOM)H65.0 und H66.0Upper respiratory tract infectionH65.0H66.0Acute serous otitis mediaAcute suppurative otitis mediaDRKS00004569Weber & Weber GmbH & Co. KGBiologische Arzneimittel311
Active, not recruiting
Not Applicable
Does a herbal-based medicine compared with a placebo (dummy drug) reduce the number of episodes with middle ear infection?recurrent acute otitis mediaMedDRA version: 16.1Level: PTClassification code 10033078Term: Otitis mediaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 16.1Level: PTClassification code 10033079Term: Otitis media acuteSystem Organ Class: 10021881 - Infections and infestationsEUCTR2012-000341-13-DEWeber & Weber GmbH & Co. KG
Completed
Phase 2
Role of Herbal Immunomodulators in mild COVID-19 confirmed casesCTRI/2020/06/025801The Himalaya Drug Company40